The relationship between 896A/G (rs4986790) polymorphism of TLR4 and infectious diseases: A meta-analysis.

التفاصيل البيبلوغرافية
العنوان: The relationship between 896A/G (rs4986790) polymorphism of TLR4 and infectious diseases: A meta-analysis.
المؤلفون: Silva MJA; Evandro Chagas Institute (IEC), Ananindeua, Brazil., Santana DS; Institute of Health Sciences (ICS), Federal University of Pará (UFPA), Belém, Brazil., de Oliveira LG; Evandro Chagas Institute (IEC), Ananindeua, Brazil., Monteiro EOL; Department of Biomedicine, University of the Amazon (UNAMA), Ananindeua, Brazil., Lima LNGC; Evandro Chagas Institute (IEC), Ananindeua, Brazil.
المصدر: Frontiers in genetics [Front Genet] 2022 Nov 24; Vol. 13, pp. 1045725. Date of Electronic Publication: 2022 Nov 24 (Print Publication: 2022).
نوع المنشور: Systematic Review
اللغة: English
بيانات الدورية: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101560621 Publication Model: eCollection Cited Medium: Print ISSN: 1664-8021 (Print) Linking ISSN: 16648021 NLM ISO Abbreviation: Front Genet Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Lausanne : Frontiers Research Foundation.
مستخلص: Toll-like Receptors (TLRs) , such as the TLR4 , are genes encoding transmembrane receptors of the same name, which induce a pro- or anti-inflammatory response according to their expression as the host's first line of defense against pathogens, such as infectious ones. Single nucleotide polymorphisms (SNPs) are the most common type of mutation in the human genome and can generate functional modification in genes. The aim of this article is to review in which infectious diseases there is an association of susceptibility or protection by the TLR4 SNP rs4986790. A systematic review and meta-analysis of the literature was conducted in the Science Direct, PUBMED, MEDLINE, and SciELO databases between 2011 and 2021 based on the dominant genotypic model of this SNP for general and subgroup analysis of infectious agent type in random effect. Summary odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were calculated for genotypic comparison. I 2 statistics were calculated to assess the presence of heterogeneity between studies and funnel plots were inspected for indication of publication bias. A total of 27 articles were included, all in English. Among the results achieved, the categories of diseases that were most associated with the SNP studied were in decreasing order of number of articles: infections by bacteria (29.63%); caused by viruses (22.23%); urinary tract infection-UTI (7.4%), while 11 studies (40.74%) demonstrated a nonsignificant association. In this meta-analysis, a total of 5599 cases and 5871 controls were finalized. The present meta-analysis suggests that there is no significant association between TLR4-rs4986790 SNP and infections (OR = 1,11; 95% CI: 0,75-1,66; p = 0,59), but in the virus subgroup it was associated with a higher risk (OR = 2,16; 95% CI: 1,09-4,30; p = 0,03). The subgroups of bacteria and parasites did not show statistical significance (OR = 0,86; 95% CI: 0,56-1,30; p = 0,47, and no estimate of effects, respectively). Therefore, it has been shown that a diversity of infectious diseases is related to this polymorphism, either by susceptibility or even severity to them, and the receptor generated is also crucial for the generation of cell signaling pathways and immune response against pathogens.
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
(Copyright © 2022 Silva, Santana, de Oliveira, Monteiro and Lima.)
References: Acta Paediatr. 2018 Feb;107(2):339-346. (PMID: 29028278)
Transplantation. 2011 Sep 27;92(6):690-6. (PMID: 21822168)
Virulence. 2016 Jul 3;7(5):512-26. (PMID: 27078171)
J Immunol. 2010 Apr 15;184(8):4362-7. (PMID: 20212095)
Front Microbiol. 2016 Jul 05;7:1003. (PMID: 27458431)
J Med Virol. 2011 Oct;83(10):1834-40. (PMID: 21837802)
J Periodontal Res. 2011 Apr;46(2):184-92. (PMID: 21118416)
Cold Spring Harb Perspect Biol. 2017 Jun 1;9(6):. (PMID: 28193722)
Inflamm Res. 2013 May;62(5):483-7. (PMID: 23417289)
Rev Panam Salud Publica. 2020 Feb 10;44:e10. (PMID: 32051684)
Immunology. 2007 Sep;122(1):124-30. (PMID: 17484770)
BMJ. 2009 Jul 21;339:b2700. (PMID: 19622552)
Clin Vaccine Immunol. 2011 Feb;18(2):217-22. (PMID: 21159925)
J Clin Periodontol. 2012 Apr;39(4):323-32. (PMID: 22324464)
J Infect Dis. 2002 Nov 15;186(10):1522-5. (PMID: 12404174)
J Immunol. 2012 May 1;188(9):4506-15. (PMID: 22474023)
J Biol Chem. 2012 Nov 23;287(48):40611-7. (PMID: 23055527)
J Med Virol. 2021 May;93(5):2735-2739. (PMID: 33506952)
Rev Lat Am Enfermagem. 2007 May-Jun;15(3):508-11. (PMID: 17653438)
Int J Prev Med. 2019 Oct 09;10:169. (PMID: 32133087)
Gene. 2018 Jan 30;641:196-202. (PMID: 29066305)
Vaccines (Basel). 2017 Oct 04;5(4):. (PMID: 28976923)
PLoS One. 2013 Nov 25;8(11):e81047. (PMID: 24282567)
J Hum Genet. 2013 Nov;58(11):707-10. (PMID: 23985798)
PLoS One. 2010 May 20;5(5):e10734. (PMID: 20505764)
Innate Immun. 2008 Aug;14(4):223-31. (PMID: 18669608)
Cad Saude Publica. 2004 Sep-Oct;20(5):1354-60. (PMID: 15486679)
Mediators Inflamm. 2021 Jan 14;2021:8874339. (PMID: 33505220)
Nature. 2009 Apr 30;458(7242):1191-5. (PMID: 19252480)
BMC Med Genet. 2011 Mar 07;12:36. (PMID: 21385363)
Nat Immunol. 2000 Nov;1(5):398-401. (PMID: 11062499)
Brain Res. 2006 May 26;1091(1):79-88. (PMID: 16579977)
Annu Rev Immunol. 2002;20:197-216. (PMID: 11861602)
Virol J. 2012 Nov 15;9:270. (PMID: 23151015)
Immunol Rev. 2000 Feb;173:89-97. (PMID: 10719670)
PeerJ. 2019 Nov 21;7:e7828. (PMID: 31772831)
Int J Pediatr Otorhinolaryngol. 2012 Jul;76(7):976-9. (PMID: 22494793)
Methods Mol Biol. 2009;530:423-33. (PMID: 19266333)
Sci Rep. 2020 Aug 4;10(1):13154. (PMID: 32753695)
Int J Immunogenet. 2012 Aug;39(4):303-7. (PMID: 22308961)
Cir Esp. 2014 Feb;92(2):82-8. (PMID: 24361098)
Rev Assoc Med Bras (1992). 1999 Jul-Sep;45(3):247-54. (PMID: 10513057)
Br J Biomed Sci. 2019 Jan;76(1):35-41. (PMID: 30421643)
J Perinatol. 2013 Oct;33(10):772-7. (PMID: 23867959)
Clin Exp Med. 2019 Feb;19(1):105-113. (PMID: 30220001)
Infect Immun. 2004 Jan;72(1):176-86. (PMID: 14688095)
Malar J. 2012 Jun 12;11:196. (PMID: 22691414)
J Inflamm Res. 2021 Nov 27;14:6293-6303. (PMID: 34866927)
Cell Immunol. 2010;260(2):128-36. (PMID: 19919859)
Front Immunol. 2014 Jul 10;5:316. (PMID: 25071777)
Br J Biomed Sci. 2019 Apr;76(2):59-63. (PMID: 30569830)
Kaohsiung J Med Sci. 2020 Mar;36(3):206-211. (PMID: 31749314)
J Periodontal Res. 2016 Apr;51(2):203-11. (PMID: 26174031)
Infect Genet Evol. 2019 Mar;68:84-90. (PMID: 30529560)
Genes (Basel). 2020 Dec 30;12(1):. (PMID: 33396586)
Nat Genet. 2000 Jun;25(2):187-91. (PMID: 10835634)
Cytokine. 2015 Jan;71(1):16-21. (PMID: 25213166)
J Infect Dis. 2007 Aug 1;196(3):475-84. (PMID: 17597463)
J Transl Med. 2013 Sep 21;11:220. (PMID: 24053111)
Immunity. 1999 Oct;11(4):443-51. (PMID: 10549626)
Nature. 1997 Jul 24;388(6640):394-7. (PMID: 9237759)
Infect Genet Evol. 2016 Sep;43:412-7. (PMID: 27302095)
Scand J Immunol. 2019 Jul;90(1):e12771. (PMID: 31054156)
PLoS Pathog. 2018 Dec 20;14(12):e1007390. (PMID: 30571771)
Scand J Immunol. 2010 Feb;71(2):99-108. (PMID: 20384861)
فهرسة مساهمة: Keywords: association studies; immunogenetics; infectious diseases; single nucleotide polymorphism; toll-like receptor 4 (TLR4)
تواريخ الأحداث: Date Created: 20221212 Latest Revision: 20221222
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC9729345
DOI: 10.3389/fgene.2022.1045725
PMID: 36506333
قاعدة البيانات: MEDLINE
الوصف
تدمد:1664-8021
DOI:10.3389/fgene.2022.1045725